Bruker Announces Contract Award for JPEO-CBD IPDS-LR Program
21 June 2012 - 9:00PM
Business Wire
Bruker today announced the award of a contract for an additional
40 systems from the Improved Point Detection System – Lifecycle
Replacement (IPDS-LR) program through the Joint Program Executive
Office for Chemical and Biological Defense (JPEO-CBD) for use by
the United States Navy. The overall effort is being managed by the
Joint Project Manager for Nuclear, Biological and Chemical
Contamination Avoidance (JPM NBC CA). The deliveries of systems
under this contract are scheduled to begin late 2012 and continue
into 2013. The total contract value to Bruker under this new award
is approximately $4.8 million.
The IPDS-LR system is based on Bruker’s RAID-S2, a trace
gas detector for the detection of chemical warfare agents (CWAs)
and toxic industrial chemicals (TICs). This system utilizes
Bruker’s proprietary high-performance ion mobility spectrometry
(IMS) technology. The RAID-S2 is designed for long-term
monitoring of ambient air for the presence of hazardous chemical
vapors in the interior or exterior of ships, buildings or
shelters.
BRUKER CAUTIONARY STATEMENT
Any statements contained in this presentation that do not
describe historical facts may constitute forward-looking statements
as that term is defined in the Private Securities Litigation Reform
Act of 1995. Any forward-looking statements contained herein are
based on current expectations, but are subject to risks and
uncertainties that could cause actual results to differ materially
from those projected, including, but not limited to, risks and
uncertainties relating to adverse changes in conditions in the
global economy and volatility in the capital markets, the
integration of businesses we have acquired or may acquire in the
future, changing technologies, product development and market
acceptance of our products, the cost and pricing of our products,
manufacturing, competition, dependence on collaborative partners
and key suppliers, capital spending and government funding
policies, changes in governmental regulations, realization of
anticipated benefits from economic stimulus programs, intellectual
property rights, litigation, and exposure to foreign currency
fluctuations and other risk factors discussed from time to time in
our filings with the Securities and Exchange Commission. These and
other factors are identified and described in more detail in our
filings with the SEC, including, without limitation, our annual
report on Form 10-K for the year ended December 31, 2011, our most
recent quarterly reports on Form 10-Q and our current reports on
Form 8-K. We expressly disclaim any intent or obligation to update
these forward-looking statements other than as required by law.
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024